GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Cyclically Adjusted Price-to-FCF

Core Laboratories (Core Laboratories) Cyclically Adjusted Price-to-FCF : 5.45 (As of Apr. 27, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Core Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Core Laboratories's current share price is $16.94. Core Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2023 was $3.11. Core Laboratories's Cyclically Adjusted Price-to-FCF for today is 5.45.

The historical rank and industry rank for Core Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

CLB's Cyclically Adjusted Price-to-FCF is not ranked *
in the Oil & Gas industry.
Industry Median: 14.51
* Ranked among companies with meaningful Cyclically Adjusted Price-to-FCF only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Core Laboratories's adjusted free cash flow per share data for the three months ended in Mar. 2023 was $-0.113. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.11 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Core Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Core Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Cyclically Adjusted Price-to-FCF Chart

Core Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.52 9.52 7.24 6.40 6.16

Core Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.94 5.80 3.81 6.16 7.08

Competitive Comparison of Core Laboratories's Cyclically Adjusted Price-to-FCF

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Core Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Core Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=16.94/3.11
=5.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Core Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.113/124.7200*124.7200
=-0.113

Current CPI (Mar. 2023) = 124.7200.

Core Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201306 1.244 98.320 1.578
201309 1.402 99.080 1.765
201312 1.727 98.360 2.190
201403 1.283 99.390 1.610
201406 1.184 99.240 1.488
201409 1.490 99.960 1.859
201412 2.020 99.050 2.544
201503 1.667 99.750 2.084
201506 0.954 100.230 1.187
201509 0.856 100.500 1.062
201512 1.055 99.730 1.319
201603 1.016 100.310 1.263
201606 0.579 100.260 0.720
201609 0.729 100.570 0.904
201612 0.439 100.710 0.544
201703 0.523 101.440 0.643
201706 0.354 101.370 0.436
201709 0.562 102.030 0.687
201712 0.936 101.970 1.145
201803 0.418 102.470 0.509
201806 0.421 103.100 0.509
201809 0.440 103.950 0.528
201812 0.724 103.970 0.868
201903 0.446 105.370 0.528
201906 0.224 105.840 0.264
201909 0.461 106.700 0.539
201912 0.371 106.800 0.433
202003 0.419 106.850 0.489
202006 0.534 107.510 0.619
202009 0.410 107.880 0.474
202012 -0.343 107.850 -0.397
202103 0.112 108.870 0.128
202106 0.139 109.670 0.158
202109 0.185 110.790 0.208
202112 0.050 114.010 0.055
202203 0.064 119.460 0.067
202206 -0.056 119.050 -0.059
202209 0.067 126.890 0.066
202212 0.241 124.940 0.241
202303 -0.113 124.720 -0.113

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Core Laboratories  (NYSE:CLB) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Core Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Laboratories (Core Laboratories) Business Description

Industry
Traded in Other Exchanges
N/A
Address
6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Executives
Katherine Murray director 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli officer: SVP, Gen Counsel & Secretary C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng director C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler officer: SVP C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith director P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique director P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland director DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno officer: President 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig officer: VP, Counsel & Secretary 6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett director 853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels officer: CAO & Treasurer 6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen director 68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes director 6316 WINDFERN ROAD, HOUSTON TX 77040